My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 232

    1.

    Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

    Vijan S, Hofer TP, Hayward RA.

    Ann Intern Med. 1997 Nov 1;127(9):788-95.PMID: 9382399 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Estimating the microvascular benefits of screening for type 2 diabetes mellitus.

    Hofer TP, Vijan S, Hayward RA.

    Int J Technol Assess Health Care. 2000 Summer;16(3):822-33.PMID: 11028137 [PubMed - indexed for MEDLINE]Related articles

    3.

    Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

    Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

    J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.PMID: 14583175 [PubMed - indexed for MEDLINE]Related articles

    4.

    Glycemic control and the risk of multiple microvascular diabetic complications.

    Schellhase KG, Koepsell TD, Weiss NS.

    Fam Med. 2005 Feb;37(2):125-30.PMID: 15690253 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.

    Crook ED, Patel S.

    Ethn Dis. 2006 Autumn;16(4):865-71.PMID: 17061739 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

    Vijan S, Hofer TP, Hayward RA.

    JAMA. 2000 Feb 16;283(7):889-96.PMID: 10685713 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Blood glucose control and microvascular and macrovascular complications in diabetes.

    Hanssen KF.

    Diabetes. 1997 Sep;46 Suppl 2:S101-3.PMID: 9285509 [PubMed - indexed for MEDLINE]Related articles

    8.

    Importance of glucose control.

    Edelman SV.

    Med Clin North Am. 1998 Jul;82(4):665-87. Review.PMID: 9706116 [PubMed - indexed for MEDLINE]Related articles

    9.

    Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

    Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M.

    Diabetes Care. 1997 May;20(5):735-44.PMID: 9135935 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

    [No authors listed]

    Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602. PMID: 9742976 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

    Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO.

    Ann Intern Med. 2008 Jul 1;149(1):11-9.PMID: 18591633 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians.

    Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians.

    Ann Intern Med. 2007 Sep 18;147(6):417-22.PMID: 17876024 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diabetes and cardiovascular disease: the role of glycemic control.

    Cheng AY, Leiter LA.

    Curr Diab Rep. 2009 Feb;9(1):65-72.PMID: 19192427 [PubMed - indexed for MEDLINE]Related articles

    14.

    The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.

    Ozmen B, Boyvada S.

    J Diabetes Complications. 2003 May-Jun;17(3):128-34.PMID: 12738396 [PubMed - indexed for MEDLINE]Related articles

    15.

    Care of adults with type 2 diabetes mellitus. A review of the evidence.

    O'Connor PJ, Spann SJ, Woolf SH.

    J Fam Pract. 1998 Nov;47(5 Suppl):S13-22. Review.PMID: 9834750 [PubMed - indexed for MEDLINE]Related articles

    16.

    Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications.

    Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, Omori Y.

    Diabetes Care. 1997 May;20(5):844-7.PMID: 9135953 [PubMed - indexed for MEDLINE]Related articles

    17.

    Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.

    Cerveny JD, Leder RD, Weart CW.

    Ann Pharmacother. 1998 Sep;32(9):896-905. Review.PMID: 9762378 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy.

    Polak BC, Crijns H, Casparie AF, Niessen LW.

    Health Policy. 2003 Apr;64(1):89-97.PMID: 12644331 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

    [No authors listed]

    BMJ. 1998 Sep 12;317(7160):713-20.PMID: 9732338 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effects of improved glycemic control on complications in type 2 diabetes.

    Gaster B, Hirsch IB.

    Arch Intern Med. 1998 Jan 26;158(2):134-40. Review.PMID: 9448551 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity